Blood clot leads to blockage of blood supply to the heart, legs, brain and lungs. Blood clots develop in the arteries and causes diseases such as stroke, heart attack and sever legs pain. In addition, formation of blood clot is also a leading cause of death in cancer patients. Blood clots are treated with anti-coagulation drugs and surgery. Clot management devices are used to treat periphery artery, neurovascular, arteriovenous and coronary thrombosis.
North America dominates the global market for clot management devices due to introduction of neurovascular embolectomy device. Asia is expected to show high growth rates in the next five years in global clot management devices market. China and India are expected to be the fastest growing clot management devices markets in Asia-Pacific region. Some of the key driving forces for clot management devices market in emerging countries are increasing investment in healthcare infrastructure, lack of prophylactic inferior vena cava filter and large pool of patients.
For More info Click Here.